exo-2-(3,6-Dichloropyridazin-4-yl)-7-azabicyclo[2.2.1]heptane-7-carboxylic Acid Ethyl Ester
Compound with spectra: 1 NMR, and 1 MS (GC)
![exo-2-(3,6-Dichloropyridazin-4-yl)-7-azabicyclo[2.2.1]heptane-7-carboxylic Acid Ethyl Ester](/api/compound/5Og18XluUbH.png?ph=true&h=300&w=458 "exo-2-(3,6-Dichloropyridazin-4-yl)-7-azabicyclo[2.2.1]heptane-7-carboxylic Acid Ethyl Ester")
| SpectraBase Compound ID | 5Og18XluUbH |
|---|---|
| InChI | InChI=1S/C13H15Cl2N3O2/c1-2-20-13(19)18-7-3-4-10(18)8(5-7)9-6-11(14)16-17-12(9)15/h6-8,10H,2-5H2,1H3/t7-,8+,10+/m1/s1 |
| InChIKey | LDIBWAFIOOCUSR-WEDXCCLWSA-N |
| Mol Weight | 316.19 g/mol |
| Molecular Formula | C13H15Cl2N3O2 |
| Exact Mass | 315.054132 g/mol |
| Enantiomer InChIKey | LDIBWAFIOOCUSR-QXFUBDJGSA-N |
| Copyright | Copyright © 2020-2024 John Wiley & Sons, Inc. All Rights Reserved. |
|---|---|
| Source of Spectrum | F2-44-53-18 |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
(1S,3R,4R)-tert-Butyl 3-(4-phenylthiazol-2-yl)-2-azabicyclo[2.2.1]heptane-2-carboxylate
dimethyl(1.alpha.,2.beta.,3.alpha.,4.beta.,5.alpha.)-3-methyl-3-phenyl-6,7-diazatricyclo[3.2.0.0(2,4)]heptane-6,7-dicarboxylate
Viomycin
N-Ethoxycarbonyl-9-ethyl-2-aza-tricyclo(4.3.1.0/3,7/)dec-8-ene
1-{2,3-Bis[4-(trifluoromethyl)phenyl]-5-(4-nitrophenyl)-1H-pyrrol-1-yl}ethanone
Diethyl 3-methyl-3-[2,5-bis(methoxymethyl)pyrrolidin-1-yl]aziridine-1,2-dicarboxylate
1-oxa-3,8-diazaspiro[4.5]decan-2-one, 3-[(4-fluorophenyl)methyl]-4-hydroxy-4,7,7,9,9-pentamethyl-
3,3-Dimethyl-2,3,8,9,10,11-hexahydro-7aH-oxazolo[2,3-j]quinolin-7-one
(3aS,8bS)-4-benzyl-8b-methyl-1,2,3,3a,4,8b-hexahydrocyclopenta[b]indole
N-Ethoxycarbonyl-7-methyl-2-aza-tricyclo(4.3.1.0/3,7/)dec-8-ene
| Title | Journal or Book | Year |
|---|---|---|
| exo-2-(Pyridazin-4-yl)-7-azabicyclo[2.2.1]heptanes: Syntheses and Nicotinic Acetylcholine Receptor Agonist Activity of Potent Pyridazine Analogues of (±)-Epibatidine | Journal of Medicinal Chemistry | 2000 |